Compare ENLV & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENLV | WEYS |
|---|---|---|
| Founded | 2005 | 1906 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.7M | 280.9M |
| IPO Year | 2014 | 1995 |
| Metric | ENLV | WEYS |
|---|---|---|
| Price | $1.03 | $32.00 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 199.5K | 16.1K |
| Earning Date | 04-29-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 3.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.41 |
| Revenue | N/A | ★ $276,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.34 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.66 | $25.51 |
| 52 Week High | $2.10 | $34.83 |
| Indicator | ENLV | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 48.67 |
| Support Level | $1.00 | $30.92 |
| Resistance Level | $1.23 | $34.06 |
| Average True Range (ATR) | 0.06 | 1.48 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 2.78 | 44.88 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.